Fresenius SE KGaA (XSWX:FRE) Capex-to-Operating-Cash-Flow: 0.50 (As of Mar. 2026) — 15% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:FRE Fresenius SE & Co KGaA XSWX:FRE
68 GF Score
Price CHF44.36
GF Value CHF33.45
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Fresenius SE KGaA Capex-to-Operating-Cash-Flow?

Fresenius SE KGaA XSWX:FRE 68 Capex-to-Operating-Cash-Flow is 0.50 as of Mar. 2026, which is 15% below its 10-year median of 0.59. GuruFocus rates XSWX:FRE with a GF Score™ of 68/100 and a GF Value™ of CHF33.45 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 380 Healthcare Providers & Services companies, Fresenius SE KGaA ranks worse than 64.47% on this metric.

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Fresenius SE KGaA's Capital Expenditure for the three months ended in Mar. 2026 was CHF-178.39 Mil. Its Cash Flow from Operations for the three months ended in Mar. 2026 was CHF354.06 Mil.

Hence, Fresenius SE KGaA's Capex-to-Operating-Cash-Flow for the three months ended in Mar. 2026 was 0.50.


Fresenius SE KGaA  (XSWX:FRE) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Fresenius SE KGaA Capex-to-Operating-Cash-Flow Related Terms


Fresenius SE KGaA Capex-to-Operating-Cash-Flow Historical Data

* Premium members only.

The historical data trend for Fresenius SE KGaA's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius SE KGaA Capex-to-Operating-Cash-Flow Chart

Fresenius SE KGaA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.60 0.28 0.29 0.43 0.58

Fresenius SE KGaA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.63 0.45 0.51 0.54 0.50

XSWX:FRE vs HCA, THC, DVA: Capex-to-Operating-Cash-Flow Comparison

For the Medical Care Facilities subindustry, Fresenius SE KGaA's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius SE KGaA Capex-to-Operating-Cash-Flow vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's Capex-to-Operating-Cash-Flow falls into.


XSWX:FRE
68GF Score
Fresenius SE & Co KGaA XSWX:FRE
Capex-to-Operating-Cash-Flow is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius SE KGaA Capex-to-Operating-Cash-Flow Calculation

Fresenius SE KGaA's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2025 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-1396.908) / 2401.898
=0.58

Fresenius SE KGaA's Capex-to-Operating-Cash-Flow for the quarter that ended in Mar. 2026 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-178.394) / 354.057
=0.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Capex-to-Operating-Cash-Flow of 0.50 mean?
Fresenius SE KGaA (XSWX:FRE) has a Capex-to-Operating-Cash-Flow of 0.50 as of Mar. 2026. Capex to Operating Cash Flow ratio assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. View historical data on Fresenius SE KGaA and its competitors. This is 15% below median its historical median of 0.59. Over the past decade, Fresenius SE KGaA's Capex-to-Operating-Cash-Flow has ranged from 0.28 to 2.06. According to the industry distribution chart, Fresenius SE KGaA ranks #245 out of 380 companies in the Healthcare Providers & Services industry, placing it in the top 64.5%.
Is Fresenius SE KGaA's Capex-to-Operating-Cash-Flow too high?
Fresenius SE KGaA's current Capex-to-Operating-Cash-Flow of 0.50 is 15% below median its 10-year median of 0.59. Over the past 10 years, this metric has ranged from a low of 0.28 to a high of 2.06. The Healthcare Providers & Services industry median Capex-to-Operating-Cash-Flow is 0.35. Fresenius SE KGaA's value of 0.50 is 42.9% above this industry median. Based on the distribution chart, Fresenius SE KGaA ranks #245 out of 380 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Fresenius SE KGaA has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's Capex-to-Operating-Cash-Flow compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #245 out of 380 companies for Capex-to-Operating-Cash-Flow. This places Fresenius SE KGaA in the lower half of its industry. The industry median Capex-to-Operating-Cash-Flow is 0.35. Fresenius SE KGaA's value of 0.50 is 42.9% above this benchmark. Historically, Fresenius SE KGaA's own Capex-to-Operating-Cash-Flow has ranged from 0.28 to 2.06 over the past decade. While the company's 10-year median is 0.59 vs. the industry median of 0.35, Fresenius SE KGaA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Capex-to-Operating-Cash-Flow for a Healthcare Providers & Services company?
The median Capex-to-Operating-Cash-Flow among Healthcare Providers & Services companies is 0.35, based on 380 companies in the industry. Companies in the top quartile (top 25%) have a Capex-to-Operating-Cash-Flow significantly above this median, while those in the bottom quartile fall well below. However, Capex-to-Operating-Cash-Flow should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius SE KGaA's current Capex-to-Operating-Cash-Flow of 0.50 is 42.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Capex-to-Operating-Cash-Flow mean?
A high Capex-to-Operating-Cash-Flow can signal that a stock is expensive relative to its fundamentals. Capex to Operating Cash Flow ratio assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. View historical data on Fresenius SE KGaA and its competitors. For the Healthcare Providers & Services industry, the median Capex-to-Operating-Cash-Flow is 0.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius SE KGaA's current Capex-to-Operating-Cash-Flow is 0.50, which is 15% below median its own 10-year median of 0.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF33.45, compared to a current price of CHF44.36 — trading 32.6% above its estimated fair value. The current Capex-to-Operating-Cash-Flow is 0.50, which is 15% below median its 10-year median of 0.59 and 42.9% above the Healthcare Providers & Services industry median of 0.35. Fresenius SE KGaA's overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Capex-to-Operating-Cash-Flow calculated?
Capex-to-Operating-Cash-Flow is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current Capex-to-Operating-Cash-Flow is 0.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued. The current stock price of CHF44.36 is trading 32.6% above its estimated GF Value™ of CHF33.45. GuruFocus considers Fresenius SE KGaA to be Significantly Overvalued.

Key valuation signals for XSWX:FRE:

  • Capex-to-Operating-Cash-Flow: 0.50 (15% below median its 10-year median of 0.59)
  • GF Value™: CHF33.45 vs. price of CHF44.36 (32.6% above fair value)
  • GF Score™: 68/100 with 6 warning signs
  • Industry Position: 42.9% above the Healthcare Providers & Services median (#245 of 380)

No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fresenius SE KGaA Business Description

Address Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
68GF Score

Get the complete analysis for XSWX:FRE

Capex-to-Operating-Cash-Flow is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF44.36
Price
CHF33.45
GF Value